We have demonstrated the sex difference with respect tothe dopaminergic
It is generally accepted that hypothalamic biogenic amines are involved in the regulation of various pituitary hormones.
It has been reported that dopamine infusion had an inhibitory effect on the TSH secretion in healthy controls (Burrows et al., 1977) and in primary hypothyroidism (Delitala, G., 1977 ; Mitsuma et al., 1978) , while 1-Dopa did not exert a suppressive effect in normal control but in primary hypothyroidism inhibitory action was seen (Rapport et al., 1973; Refetoff et al., 1974; Eddy et al., 1977) .
Further evidence of the physiological inhibitory role of dopamine has been provided by a rise in serum TSH in response to the specific dopamine receptor blocking drug with metoclopramide in normal healthy controls (Healy and Burger, 1977; Scanlon et al., 1977) .
It is reported that domperidone (Domp) was found to be a very potent and specific dopamine receptor blocking drug, which could not readily cross the blood brain barrier and did not elicit a marked HVA increase as was found with classical neuroleptic drugs and metoclopramide (Laduron and Leysen, 1979) . reported by Scanlon et al. (1977) and Delitala et al. (1980) . The present observation indicates that there is a sex difference with respect to dopaminergic modulation of TSH secretions in hypothyroidism.
A possible role of oestrogens in modulating the secretion of TSH from the pituitary gland is suggested from the observations of Adams & Maloof (1979) who described a 3-to 10-fold increase In serum TSH in normal males following administration of ethynil oestradiol.
Furthermore, Fagilia et al. (1973) reported the enhancement of responsiveness to TRH after the administration of 10 mg of oestradiol valerate to males.
Neuropharmacological studies indicate that Domp is a highly potent and specific dopaminergic receptor blocking agent which did not elicit marked HVA and dopamine sensitive adenyl cyclase (Laduron and Leysen, 1979) .
Domp induced a significant increase in prolactin secretion, as described previously (Kamijo et al., 1979 ; Scanlon et al., 1980) .
Our finding provided evidence of sex difference in dopaminergic modulation of TSH secretion in hypothyroid patients, although the mechanism involved in hypothyroid patients remains unclarified at present.
